Andrew J Grethlein sold $3.1M of GERN
EVP, Chief Operating Officer at GERON CORP. 674,348 shares at an average of $4.56, traded Jul 8, 2024, filed Jul 10, 2024.
Score components
- +20RoleCOO
- +25Trade size$3.1M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +2.2%, 3m -8.3%, 6m -25.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-082686, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 8, 2024 | MOption exercise Common Stock | +674,348 | $1.72 | $1.2M | 674,348 | Jul 10, 2024 |
| Jul 8, 2024 | SOpen-market sale Common Stock | -674,348 | $4.56 | $3.1M | 0 | Jul 10, 2024 |
| Jul 8, 2024 | MOption exercise Stock Option (right to buy)derivative | -221,544 | $0.00 | $0 | 0 | Jul 10, 2024 |
| Jul 8, 2024 | MOption exercise Stock Option (right to buy)derivative | -452,804 | $0.00 | $0 | 0 | Jul 10, 2024 |
Related signals
Other insiders at GERON CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 17Weak | GERNsell GERON CORP | Michelle Robertson EVP, CHIEF FINANCIAL OFFICER | $19k 9,855 shares | -36% | |
| 41Moderate | GERNbuy GERON CORP | Bryan Lawlis V director | $16k 13,300 shares | - | |
| 49Moderate | GERON CORP | James Ziegler EVP, Chief Commercial Officer | $160k 100,000 shares | - | |
| 48Moderate | GERON CORP | John A Scarlett Chairman, President and CEO | $22k 12,500 shares | - | |
| 40Moderate | GERON CORP | Scott Alan Samuels EVP, Chief Legal Officer | $24k 15,000 shares | +128% | |
| 60Notable | GERON CORP | Faye Feller EVP, Chief Medical Officer | $1.3M 287,900 shares | -100% | |
| 60Notable | GERON CORP | Anil Kapur EVP, Corp Strategy & CCO | $2.0M 421,875 shares | -100% | |
| 50Moderate | GERON CORP | John A Scarlett Chairman, President and CEO | $2.4M 600,000 shares | -50% | |
| 11Weak | GERON CORP | Bryan Lawlis V director | $131k 35,000 shares | -100% | |
| 32Weak | GERON CORP | Olivia Kyusuk Bloom EVP, Chief Financial Officer | $1.2M 400,000 shares | -84% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.